Download Free Medical The Impact of COVID-19 on Cancer Treatment in France PowerPoint Presentation

The Impact of COVID-19 on Cancer Treatment in France PowerPoint Presentation

DOWNLOAD MEDICAL POWERPOINT PRESENTATION

About This Presentation

Description : This report titled, “The Impact of COVID-19 on Cancer Treatment in France” is by the IQVIA Institute and is a voluntary, unpaid, IQVIA-sponsored survey of Oncologists, Hem-oncologists and Onco-surgeons examining the impact of coronavirus COVID-19 on cancer treatment in France.

Tags : Healthcare, Oncology, cancer, Cancer Treatment, COVID-19, France, Oncologists, Hem-oncologists, Onco-surgeons

Published on : Jul 20, 2020 | Views : 2503 | Downloads : 0

Shareable Url :

Embed Code :

Comment

Transcript

Slide 1-

© 2020. All rights reserved. IQVIA® is a registered trademark of IQVIA Inc. in the United States, the European Union, and various other countries. France Report Impact of COVID-19 on Cancer Treatment
Slide 2-

1 Overview What is the purpose of this report? The purpose of this report is to determine if there has been any changes reported in the treatment of cancer across France now as restrictions ease and exit lockdown We will be comparing what Onco Specialists are telling us now (Wave 2) vs what they said at the start of the pandemic (Wave 1) The information gathered from IQVIA’s Onco Specialists community provides insight and understanding into key topics such as: The impact of cancer patient visits at different phases during COVID -19 Interaction via telehealth/ remote consultations during difference phases of the pandemic What specific type of treatment practices are impacted? What are the current changes anticipated now that restrictions are being relaxed? What pharma/biotech initiatives can help Onco Specialists deliver the best care possible their patients What communication channels are pharma companies using to communicate with Onco Specialists? How and When was the data collected? Onco Specialists were invited to participate via email and the survey was hosted on DocNet – IQVIA’s internal and secure online community for healthcare professionals This survey was not sponsored by any IQVIA client/customer. IQVIA was not compensated in any way for this survey Data collection occured from the 17th of June – 22nd of June 2020 (Wave 2) We will be comparing results with our Wave 1 survey that took place between 2nd of April – 6th of April 2020 (Wave 1) Impact of COVID-19 on cancer treatment – France June 2020. Copyright 2020 IQVIA. All rights reserved.
Slide 3-

Across France, 70 Onco Specialists voluntarily participated in a 3 mins survey that IQVIA hosted on DOCNET 29% Hematologist 9% Hem-Oncologist 49% Oncologists 10% Onco-surgeon 3% Radiotherapists 1% Others* Wave 2 (n=70) Impact of COVID-19 on cancer treatment – France June 2020. Copyright 2020 IQVIA. All rights reserved. 2 Sample split *Others include pulmonologists treating cancer etc. Q0. Which of the following best describes your primary medical specialty?
Slide 4-

Surprisingly, the number of cancer patients seen per week have not changed as restrictions ease and remains significantly lower than pre COVID days Average* number of cancer patients seen prior to COVID-19 outbreak Average number of cancer patients seen per week (Wave 1) Average number of cancer patients seen last week (Wave 2) 67 Patients 37 Patients 37 Patients Pandemic Outburst Exiting Lockdown Q1: After the COVID-19 outbreak, are you seeing fewer hematology/oncology patients per week? Impact of COVID-19 on cancer treatment – France June 2020. Copyright 2020 IQVIA. All rights reserved. 3 Impact on number of cancer patient seen due to COVID 19 outbreak Wave 2 (n=39) Wave 1 (n=31) * Weighted average of Wave 1 and Wave 2 Note: All numbers shown in slide are absolute numbers (number of patients)
Slide 5-

Wave 1 Wave 2 Delay in surgeries 80% 65% 68% 64% 51% 36% Delayed chemotherapy Lesser biopsy/ diagnosis Impact of COVID-19 on cancer treatment – France June 2020. Copyright 2020 IQVIA. All rights reserved. 4 Q3: What according to you is the impact on cancer treatment practice amidst the COVID-19 crisis? Impact of COVID 19 crisis on cancer treatment Wave 2 (n=70) Wave 1 (n=40) A significant level of improvement was observed vs wave 1 on lesser biopsies, delay in surgeries and chemotherapies
Slide 6-

Restrictions led to a huge spike in remote consultations (3% to 57%), however with time, Onco Specialists believe the situation would reinstate to normal 3% Prior to COVID outbreak 57% During lockdown 25% Post lockdown 11% When COVID won’t exist % proportion of patients on remote consultations Q2: Could you please estimate the typical proportion of interaction via telehealth/remote consultation in the following time period? Impact of COVID-19 on cancer treatment – France June 2020. Copyright 2020 IQVIA. All rights reserved. 5
Slide 7-

11% Patients Physicians Hospitals Increased remote consultations, limited visitor policies and change in treatment schedule to introduce orals therapies are some of the key practice changes seen by Onco Specialists Change in treatment protocol to introduce oral cancer medications Change treatments to include cancer medications which patients can self- administer Addition of more surgery days/ chemo cycles Increased daily working hours Increased frequency of remote consultations Refer patients to other facilities due to lack of hospital infrastructure 40% 10% 30% 29% 70% Limited visitor policy except in case of end of life circumstances 60% 49% Allow in-person visits primarily for critical and/or newly diagnosed cancer patients Q4: What key changes are you currently seeing in your practice setting as we see restrictions being relaxed to some extent now? Impact of COVID-19 on cancer treatment – France June 2020. Copyright 2020 IQVIA. All rights reserved. 6
Slide 8-

To maintain social distancing, E-mails, and phone calls have become current new modes to connect with Onco Specialists Current modes of communication Physicians’ expectations from pharma companies E-mail Virtual Meetings Webinars Post / Direct Mail Phone Call Messaging app No Contacts Q5: What initiatives can pharma/biotech take in order to help you manage increased cancer patients in the coming few months? 71% 37% 39% 23% 21% 47% 13% To increase patient support services 60% 54% Update on the availability of critical oncology drugs for their patients Tips on how to best communicate remotely with the rest of their practice and patients 40% Availability of an online resource center which can be accessed for product related information 40% Face to face 20% Q6: In the current COVID-19 scenario, which of the following communication channels are pharma companies using to communicate with you? Impact of COVID-19 on cancer treatment – France June 2020. Copyright 2020 IQVIA. All rights reserved. 7
Slide 9-

8 DISCLAIMER Sample size is not representative at country level. Sample composition varies at the country level. Sample sizes are different between Wave 1 and Wave 2 – Its important to keep that in mind when making comparisons between the changes observed in responses. In addition, some Oncology specialists might be responding to questions based on what they have actually experienced, whilst others may be based on what they believe might happen. This was a pulse survey. The questions asked are intended to provide top level insight into what Oncology specialists across the country are experiencing. Impact of COVID-19 on cancer treatment – France June 2020. Copyright 2020 IQVIA. All rights reserved.
Slide 10-

© 2020. All rights reserved. IQVIA® is a registered trademark of IQVIA Inc. in the United States, the European Union, and various other countries. For further information, please contact: GlobalPI@IQVIA.com

User Presentation
Related Presentations

The Impact of COVID-19 on Cancer Treatment in Spain

By: docshare
Views: 1689

Emerging Biopharma’s Contribution to Innovation

By: docshare
Views: 1398

The Amazing Trends in Wellness Retail

By: docshare
Views: 1535

The Complete GUIDE TO HOSPITAL MARKETING

By: docshare
Views: 1750

Fight to Reduce Cancer Mortality

By: docshare
Views: 1401

Skin Cancer

By: JenniferDwayne
Views: 2255

Temozolomide resistance in glioblastoma multiforme (GBM)

By: drdwayn
Views: 2055

Pancreatic Carcinoma

By: drdwayn
Views: 3711

Skin Cancer: What You Should Know

By: drdwayn
Views: 2051

Cancer

By: drdwayn
Views: 2217

docshare

About : I am a passionate medical marketing professional with hands on experience in healthcare digital marketing.
Occupation : Medical Professional
Specialty : Other Health Professionals
Country : India
Website :

HEALTH A TO Z